Ovarian Cancer Pathogenesis: A Model in Evolution

被引:210
作者
Karst, Alison M. [1 ]
Drapkin, Ronny [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, 44 Binney St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1155/2010/932371
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Ovarian cancer is a deadly disease for which there is no effective means of early detection. Ovarian carcinomas comprise a diverse group of neoplasms, exhibiting a wide range of morphological characteristics, clinical manifestations, genetic alterations, and tumor behaviors. This high degree of heterogeneity presents a major clinical challenge in both diagnosing and treating ovarian cancer. Furthermore, the early events leading to ovarian carcinoma development are poorly understood, thus complicating efforts to develop screening modalities for this disease. Here, we provide an overview of the current models of ovarian cancer pathogenesis, highlighting recent findings implicating the fallopian tube fimbria as a possible site of origin of ovarian carcinomas. The ovarian cancer model will continue to evolve as we learn more about the genetics and etiology of this disease.
引用
收藏
页数:13
相关论文
共 132 条
[1]
Establishment of a ciliated epithelial cell line from human Fallopian tube [J].
Ando, H ;
Kobayashi, M ;
Toda, S ;
Kikkawa, F ;
Masahashi, T ;
Mizutani, S .
HUMAN REPRODUCTION, 2000, 15 (07) :1597-1603
[2]
Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches [J].
Auersperg, N ;
Ota, T ;
Mitchell, GWE .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (06) :691-703
[3]
AUERSPERG N, 1994, LAB INVEST, V71, P510
[4]
Identifying symptoms of ovarian cancer: a qualitative and quantitative study [J].
Bankhead, C. R. ;
Collins, C. ;
Stokes-Lampard, H. ;
Rose, P. ;
Wilson, S. ;
Clements, A. ;
Mant, D. ;
Kehoe, S. T. ;
Austoker, J. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 115 (08) :1008-1014
[5]
A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].
BAST, RC ;
KLUG, TL ;
STJOHN, E ;
JENISON, E ;
NILOFF, JM ;
LAZARUS, H ;
BERKOWITZ, RS ;
LEAVITT, T ;
GRIFFITHS, CT ;
PARKER, L ;
ZURAWSKI, VR ;
KNAPP, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887
[6]
REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA [J].
BAST, RC ;
FEENEY, M ;
LAZARUS, H ;
NADLER, LM ;
COLVIN, RB ;
KNAPP, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1331-1337
[7]
Bast Robert C Jr, 2002, Cancer Treat Res, V107, P61
[8]
CA 125 production and release by ovarian cancer cells in vitro [J].
Beck, EP ;
Moldenhauer, A ;
Merkle, E ;
Kiesewetter, F ;
Jäger, W ;
Wildt, L ;
Lang, N .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1998, 13 (04) :200-206
[9]
Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209
[10]
ESTABLISHMENT OF HUMAN AMPULLARY CELL-CULTURES [J].
BONGSO, A ;
CHYE, NS ;
SATHANANTHAN, H ;
LIAN, NP ;
RAUFF, M ;
RATNAM, SS .
HUMAN REPRODUCTION, 1989, 4 (05) :486-494